GAS6 and COVID-19: In critically ill COVID-19 patients, alveolar damage is associated with vessel injury and thrombotic activation and an increase in Gas6/TAM levels in these patients might explain the abnormal coagulation parameters linked to COVID-19 [148] (Figure 3).